Attempts to develop new antibiotics are failing because the projects aren’t profitable. To make new drugs, it seems, pharma companies need more money.
The Antibiotics Business Is Broken—But There's a Fix
Attempts to develop new antibiotics are failing because the projects aren’t profitable. To make new drugs, it seems, pharma companies need more money.
